Lipid Insights

The primary results from the Lp(a)HORIZON trial were presented at the AHA Scientific Sessions in Chicago on November 7, 2026. Although pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the trial did not reduce the risk of major adverse cardiovascular events (MACE). Lp(a) remains an important and independent risk factor for ASCVD, so what comes next?

In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with two leading Lp(a) experts, Michael B. Boffa, PhD, and Marlys L. Koschinsky, PhD, FNLA, to react to the results and discuss what they mean for Lp(a) in cardiovascular prevention.

A timely listen for anyone looking to understand where Lp(a) science and clinical practice go from here.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice | Month 3 Podcast

Knowing the guidelines is one thing. Putting them into practice is another. In the third installment of this four-part CME/CE-accredited series, the conversation shifts from risk assessment to treatment — tackling the clinical decisions that define how we manage patients with dyslipidemia day to day.

This episode covers the new lipid treatment targets established by the 2026 Multi-Society Dyslipidemia Guideline, updated statin initiation thresholds, treatment goals across primary and secondary prevention, strategies for intensifying therapy when patients aren’t at goal, and the growing role of multidisciplinary care in optimizing long-term outcomes.

This episode is a companion piece to the Month 3 webinar, “Goals Are Back! LDL-C, Non-HDL-C, and ApoB in Clinical Practice.” We encourage you to check it out as the two were built to work together. WATCH WEBINAR

CME/CE Credit: This activity has been approved for AMA PRA Category 1 Credit and is eligible for ACPE, ANCC, and CDR credit. CME/CE credit is provided by the National Lipid Association. Claim your credit and complete the activity assessment at lipid.org/from-cholesterol-to-dyslipidemia-month-three/. Questions? Contact [email protected].

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

What do we really know about cholesterol... and what are we missing? In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as “Dr. Lipid” — for a deep dive into the world of sterols and what Dr. Dayspring has coined “sterology.”

Dr. Dayspring breaks down why cholesterol is so fundamentally important to cellular function, how cells defend against excess cholesterol buildup, how gut microflora influence cholesterol absorption, and the fascinating role of ABCG5 and ABCG8. Equal parts chemistry lesson and clinical revelation with Dr. Lipid!

Follow @drlipid on X (Twitter) and LinkedIn.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

Two podcasts. One conversation. A meeting of minds at the intersection of lipidology and cardiovascular pharmacy.

In this special collaboration episode, Lipid Insights joins forces with The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest for a wide-ranging discussion on where lipid management stands today and where it's heading. Host Craig J. Beavers, PharmD sits down with NLA Executive Council Chair Michael J. Wilkinson, MD, FNLA for a conversation that every cardiovascular clinician and pharmacist needs to hear right now. 

The discussion spans the 2026 Multi-Society Dyslipidemia Guideline and what implementation actually looks like in practice; the current state of Lp(a) science and what clinicians should be doing about it today; the cardiovascular risk implications of inflammatory diseases and how they should shape patient management; and the return to threshold-based lipid targets. 

A timely and clinically rich conversation that reflects the best of what happens when two communities dedicated to cardiovascular health sit down together.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice | Month 2 Podcast

LDL-C alone doesn't tell the whole story, and the 2026 Multi-Society Dyslipidemia Guideline makes that clear. In the second installment of this four-part CME/CE-accredited series, host Kaye-Eileen Willard, MD, FNLA sits down with Jessica Peña, MD, FNLA and Ann Marie Navar, MD, PhD to dig into the biomarkers reshaping cardiovascular risk assessment: ApoB vs. LDL-C discordance, the role of Lp(a) in everyday practice, and how clinicians can effectively use CAC scoring to guide patient management.

This episode is a companion piece to the Month 2 webinar, “Risk Assessment in 2026: PREVENT, ApoB, Lp(a), and CAC.” We encourage you to check it out as the two were built to work together. WATCH WEBINAR

CME/CE Credit: This activity has been approved for AMA PRA Category 1 Credit and is eligible for ACPE, ANCC, and CDR credit. CME/CE credit is provided by the National Lipid Association. Claim your credit and complete the activity assessment at https://www.lipid.org/from-cholesterol-to-dyslipidemia-month-two/. Questions? Contact [email protected].

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

In honor of FH Awareness Day, this special Lipid Insights episode features a conversation with Jose Lopez, MS, recipient of the Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award at the 2026 NLA Scientific Sessions.

Guest host and Foundation of the NLA President Ann Liebeskind, MD, FNLA, FAAP sits down with Jose to discuss his award-winning abstract, "Early Detection of Familial Hypercholesterolemia Through Point of Care Testing in 2-Year-Olds" — exploring the promise of point-of-care lipid testing in very young children as a practical strategy for identifying FH.

A timely and important listen for any clinician committed to closing the gap in FH detection. 

Watch the video version on YouTube HERE.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

The 2026 Multi-Society Dyslipidemia Guideline introduced significant changes; but, this episode isn't just about what's new. It's about why the field decided a change was necessary in the first place. 

In the first installment of this four-part CME/CE-accredited series, host Dave Dixon, PharmD, CLS, FNLA sits down with NLA President Dinesh Kalra, MD, FNLA and Salim Virani, MD to unpack the foundational shift from cholesterol-focused care to a broader dyslipidemia paradigm. The conversation covers why atherogenic lipoprotein exposure earlier in life matters, the key clinical misconceptions embedded in the prior guideline, and what clinicians most commonly misunderstand about lipid risk.

This episode is a companion piece to the Month 1 webinar, From Cholesterol to Dyslipidemia: What Changed in the 2026 Guideline? We encourage you to check it out as the two were built to work together: https://youtu.be/9v4WBVfKsho. 

CME/CE Credit: This activity has been approved for AMA PRA Category 1 Credit and is eligible for ACPE, ANCC, and CDR credit. CME/CE credit is provided by the National Lipid Association. Claim your credit and complete the activity assessment at https://www.lipid.org/new-dyslipidemia-paradigm-month-one/. Questions? Contact [email protected].

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science and its implications for clinical practice. Host Peter H. Jones, MD, MNLA sits down with Christie M. Ballantyne, MD, MNLA to discuss the 12-month pivotal trial results from SHASTA-3 and SHASTA-4 — evaluating plozasiran in patients with severe hypertriglyceridemia. If you missed Munich, this is your catch-up.

Watch the video version on YouTube HERE.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

Familial chylomicronemia syndrome (FCS) is one of the rarest and most challenging lipid disorders to manage, but the landscape is changing rapidly. In this Industry Innovations episode, guest host Kevin Maki, PhD, CLS, MNLA sits down with Archna Bajaj, MD, FNLA for a comprehensive and forward-looking conversation on FCS from every angle.

Dr. Bajaj walks through the realities of living with FCS — from diagnosis to the demands of a strict ultra-low-fat diet — before turning to what has the field buzzing: two landmark APOC3-targeting therapies and the clinical trial data behind them. A must-listen for any clinician caring for patients with rare lipid disorders, and a glimpse at a future where FCS management looks fundamentally different.

This episode's topic comes courtesy of Arrowhead Pharmaceuticals, Inc. a member of the NLA Industry Council.

Watch this episode on YouTube HERE.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.

In this Lipid Insights episode, host Peter H. Jones, MD, MNLA sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "Dr. Lipid" — for a deep dive into one of lipidology's most complex and frequently misrepresented topics: HDL-Cholesterol.

From the history of HDL and how our understanding of it has evolved over decades, to a true microscope-level look at HDL biochemistry and functionality, Dr. Dayspring does what he does best: peeling back the layers to reveal what HDL is really telling us and what it isn't.

Follow @drlipid on X (Twitter) and LinkedIn.

The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!

For all things lipidology, visit the NLA's website.